Journal of Alzheimer s Disease · 2016 · 20 citations · 29 references
Life SciencesNeurologyNeuroscienceDementiaMolecular NeuroscienceNeurodegenerationAlzheimer DiseaseMolecular Basis Of NeurodegenerationNeurodegeneration MechanismsNeurodegenerative DiseasesNeurodegenerative DisordersTau PathologyAnimal Disease ModelsTau HyperphosphorylationTau Protein AggregationTau TruncationTherapeutic Efficacy AssessmentTherapeutic Vaccine EfficacyTransgenic MiceTransgenic Mouse Models
Alzheimer's disease (AD) represents the most common neurodegenerative disorder. Several animal models have been developed in order to test pathophysiological mechanisms of the disease and to predict effects of pharmacological interventions. Here we examine the molecular and behavioral features of R3m/4 transgenic mice expressing human non-mutated truncated tau protein (3R tau, aa151-391) that were previously used for efficacy testing of passive tau vaccine. The mouse model reliably recapitulated crucial histopathological features of human AD, such as pre-tangles, neurofibrillary tangles, and neuropil threads. The pathology was predominantly located in the brain stem. Transgenic mice developed mature sarkosyl insoluble tau complexes consisting of mouse endogenous and human truncated and hyperphosphorylated forms of tau protein. The histopathological and biochemical features were accompanied by significant sensorimotor impairment and reduced lifespan. The sensorimotor impairment was monitored by a highly sensitive, fully-automated tool that allowed us to assess early deficit in gait and locomotion. We suggest that the novel transgenic mouse model can serve as a valuable tool for analysis of the therapeutic efficacy of tau vaccines for AD therapy.
29
Ayodeji A. Asuni, Allal Boutajangout, David Quartermain et al. · Journal of Neuroscience · 2007 · 506 citations · Full text